Cargando…

Interaction between OCT1 and LPIN1 polymorphisms and response to pioglitazone-metformin tablets in patients with polycystic ovary syndrome

Detalles Bibliográficos
Autores principales:	Zeng, Haixia, Huang, Yanting, Liu, Dengke, Xie, Tianqin, Chen, Zheng, Huang, Qiulan, Zhou, Xiaojun, Lai, Xiaoyang, Liu, Jianping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344498/ https://www.ncbi.nlm.nih.gov/pubmed/37232475 http://dx.doi.org/10.1097/CM9.0000000000002322

Ejemplares similares

Comparison clinical and metabolic effects of metformin and pioglitazone in polycystic ovary syndrome
por: Shahebrahimi, Karoon, et al.
Publicado: (2016)

Association between Polymorphisms of OCT1 and Metabolic Response to Metformin in Women with Polycystic Ovary Syndrome
por: Chang, Hui Hua, et al.
Publicado: (2019)

Evaluating the effect of insulin sensitizers metformin and pioglitazone alone and in combination on women with polycystic ovary syndrome: An RCT
por: Sohrevardi, Seyed Mojtaba, et al.
Publicado: (2016)

Formulation and Evaluation of Multilayered Tablets of Pioglitazone Hydrochloride and Metformin Hydrochloride
por: Chowdary, Y. Ankamma, et al.
Publicado: (2014)

Metabolomics Reveals Reduction of Metabolic Oxidation in Women with Polycystic Ovary Syndrome after Pioglitazone-Flutamide-Metformin Polytherapy
por: Vinaixa, Maria, et al.
Publicado: (2011)

Beneficial effects of pioglitazone and metformin in murine model of polycystic ovaries via improvement of chemerin gene up-regulation
por: Kabiri, Nahid, et al.
Publicado: (2014)

Low-Dose Spironolactone-Pioglitazone-Metformin Normalizes Circulating Fetuin-A Concentrations in Adolescent Girls with Polycystic Ovary Syndrome
por: Díaz, Marta, et al.
Publicado: (2018)

Molecular analysis of LPIN1 in Jordanian patients with rhabdomyolysis
por: Jaradat, Saied A., et al.
Publicado: (2015)

Use of dexamethasone in acute rhabdomyolysis in LPIN1 deficiency
por: Yeganeh, Mehdi, et al.
Publicado: (2023)

Pioglitazone Metformin Complex Improves Polycystic Ovary Syndrome Comorbid Psychological Distress via Inhibiting NLRP3 Inflammasome Activation: A Prospective Clinical Study
por: Guo, Qing-jun, et al.
Publicado: (2020)

Metformin combined with spironolactone vs. metformin alone in polycystic ovary syndrome: a meta-analysis
por: Zeng, Huamin, et al.
Publicado: (2023)

Simultaneous Estimation of Metformin Hydrochloride and Pioglitazone Hydrochloride by RPHPLC Method from Combined Tablet Dosage Form
por: Sahoo, P. K., et al.
Publicado: (2008)

Ontogenetic Expression of Lpin2 and Lpin3 Genes and Their Associations with Traits in Two Breeds of Chinese Fat-tailed Sheep
por: Jiao, Xiao-Li, et al.
Publicado: (2016)

Pioglitazone Enhances Mitochondrial Biogenesis and Ribosomal Protein Biosynthesis in Skeletal Muscle in Polycystic Ovary Syndrome
por: Skov, Vibe, et al.
Publicado: (2008)

An investigation into the therapeutic effects of statins with metformin on polycystic ovary syndrome: a meta-analysis of randomised controlled trials
por: Sun, Jie, et al.
Publicado: (2015)

A rare case of pediatric recurrent rhabdomyolysis with compound heterogenous variants in the LPIN1
por: Che, Ruochen, et al.
Publicado: (2020)

Metformin Treatment May Increase Omentin-1 Levels in Women With Polycystic Ovary Syndrome
por: Tan, Bee K., et al.
Publicado: (2010)

Effects of metformin use in pregnant patients with polycystic ovary syndrome
por: Kumar, Pratap, et al.
Publicado: (2012)

Role of Metformin in Polycystic Ovary Syndrome (PCOS)-Related Infertility
por: Attia, Ghalia M, et al.
Publicado: (2023)

Editorial: Polycystic ovary syndrome (PCOS): Mechanism and management
por: Wang, Yishu, et al.
Publicado: (2022)

Genetic Effects of LPIN1 Polymorphisms on Milk Production Traits in Dairy Cattle
por: Han, Bo, et al.
Publicado: (2019)

IL-33-Induced Transcriptional Activation of LPIN1 Accelerates Breast Tumorigenesis
por: Kim, Jin-Young, et al.
Publicado: (2021)

LPIN1 rhabdomyolysis: A single site cohort description and treatment recommendations
por: Kanderi, Navya, et al.
Publicado: (2022)

LPIN1 Is a Regulatory Factor Associated With Immune Response and Inflammation in Sepsis
por: Dai, Wei, et al.
Publicado: (2022)

Effect of oral contraceptives and/or metformin on GLP-1 secretion and reactive hypoglycaemia in polycystic ovary syndrome
por: Glintborg, Dorte, et al.
Publicado: (2017)

Editorial: Polycystic ovary syndrome: mechanism and management—volume II
por: Wang, Yishu, et al.
Publicado: (2023)

Weight reduction and pioglitazone ameliorate polycystic ovary syndrome after removal of a Sertoli-stromal cell tumor
por: Baba, Tsuyoshi, et al.
Publicado: (2012)

Myocardial Lipin 1 knockout in mice approximates cardiac effects of human LPIN1 mutations
por: Chambers, Kari T., et al.
Publicado: (2021)

Effect of Metformin on Serum Ferritin Level in Women with Polycystic Ovary Syndrome
por: Behradmanesh, S, et al.
Publicado: (2011)

Efficacy and safety of metformin or oral contraceptives, or both in polycystic ovary syndrome
por: Yang, Young-Mo, et al.
Publicado: (2015)

Clinical outcome of various metformin treatments for women with polycystic ovary syndrome
por: Matsuzaki, Toshiya, et al.
Publicado: (2017)

Metformin improves polycystic ovary syndrome in mice by inhibiting ovarian ferroptosis
por: Peng, Qingjie, et al.
Publicado: (2023)

Impaired Prolactin-Lowering Effects of Metformin in Women with Polycystic Ovary Syndrome
por: Krysiak, Robert, et al.
Publicado: (2023)

Simultaneous Estimation of Metformin and Pioglitazone by Ultraviolet Spectrophotometry
por: Goswami, Laxmi, et al.
Publicado: (2010)

LPIN1 deficiency: A novel mutation associated with different phenotypes in the same family
por: Nunes, D, et al.
Publicado: (2016)

Metformin improved health-related quality of life in ethnic Chinese women with polycystic ovary syndrome
por: Huang-TzOu, et al.
Publicado: (2016)

Effects of metformin on pregnancy outcome, metabolic profile, and sex hormone levels in women with polycystic ovary syndrome and their offspring: a systematic review and meta-analysis
por: Zhu, Daiyu, et al.
Publicado: (2022)

Metformin Therapy Decreases Hyperandrogenism and Ovarian Volume in Women with Polycystic Ovary Syndrome
por: Farimani Sanoee, Marzieh, et al.
Publicado: (2011)

Metformin increases pressure pain threshold in lean women with polycystic ovary syndrome
por: Kiałka, Marta, et al.
Publicado: (2016)

Metformin Ameliorates Uterine Defects in a Rat Model of Polycystic Ovary Syndrome
por: Zhang, Yuehui, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rlo16uphcctl5l1dtg4e8cl7cg